In doing so, we innovate solutions that help our customers overcome their challenges or capitalize on opportunities provided by the fast-changing world and secular trends.

We do this by continuously improving our offerings with additional resources aimed at improving customer success.” 

The SealSafe® bottle dosing adapter lets consumers dose medicine the same way professionals do in a health-care setting – by inserting a syringe in the bottle, turning it over to eliminate air bubbles, and drawing a precise measure into the syringe.

Not only do shorter cycles cut machine-related costs per part, they also reduce energy requirements to bring total system cost down even further.

What we do: Materials Science

In doing so, we innovate solutions that help our customers overcome their challenges or capitalize on opportunities provided by the fast-changing world and secular trends.

Long glass fiber reinforced engineering resins with enhanced mechanical properties that obtain metal-like structural capabilities. Download this guide to learn how to design ribs, bosses, and other features that stand the test of time, better ways to process LFT materials, what to do to minimize part defects and more about Complēt™ and OnForce™ Long Fiber Reinforced Thermoplastic Composites

You can identify these statements by the fact that they do not relate strictly to historic or current facts. Climate change continues to be one of the defining issues of our time, and at Avient, we are dedicated to do our part. Avient’s PCR Color Prediction Service helps me achieve this objective… The Redken launch would not have been possible without this service.”

se sídlem Pobřežní 620/3, 186 00 Praha, IČO 26689537, zapsanou v obchodním rejstříku vedeném u Městského soudu v Praze pod spisovou značkou č. Czech Republic Branch, se sídlem Pobřežní 620/3, 186 00 Praha, IČO 07410026, zapsanou v obchodním rejstříku vedeném u Městského soudu v Praze pod spisovou značkou č. Kupující musí o takovém převzetí informovat prodávajícího do deseti (10) dnů od jeho uskutečnění.

Microsoft PowerPoint - AVNT Q3 2024 Earnings Presentation_10.29_12PM AVIENT CORPORATION T H I R D Q U A R T E R 2 0 2 4 R E S U L T S A N D 2 0 2 4 F I N A N C I A L G U I D A N C E (NYSE: AVNT) O C T O B E R 3 1 , 2 0 2 4 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the fact that they do not relate strictly to historic or current facts. EBITDA $130 million +6% (+7% ex FX)Net Sales $815 million +8% (+8.5% ex FX) Net Sales $815 million +8% (+8.5% ex FX) Q 3 2 0 2 4 R E S U L T S TOTAL COMPANY ( Q 3 2 0 2 4 P E R F O R M A N C E V S Q 3 2 0 2 3 ) $754 $815 Q3 23 Q3 24 $123 $130 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) $0.57 $0.65 Q3 23 Q3 24 (in millions) Adjusted EBITDA Adjusted EPS 5 + 8% (+8.5% excluding FX) + 6% (+7% excluding FX) + 14% (+16% excluding FX) Sales 6 Q3 2 024 RESULTS – ORGA NI C REVENUE GROW TH BY REGI ON VS PY 6 US & Canada Latin America EMEA Asia +9% +5% +11% +27% Avient ex.